Tubin S., M.Valeriani, M.F.Osti, V.De Sanctis, A.Stopacciaro, P.Cardelli, G. Minniti, S. Gerardo, S.Bracci, R.M.Enrici “ Manipulation of radiation-induced bystander effect in prostate adenocarcinoma by dose and tumor differentiation grade”, IJRB 2014
Tubin S., Raunik W., „Hunting for Abscopal and Bystander Effects: Clinical Exploitation of Non-Targeted Effects Induced by Partial High-Single-Dose Irradiation of the Hypoxic Tumour Segment in Oligometastatic Patients”, Acta Onc. 2017
Tubin S., Mansoor M. A., Seema G., “Radiation and Hypoxia-Induced Non-Targeted Effects in Normoxic and Hypoxic Conditions in Human Lung Cancer Cells.” IJRB 2017
Tubin S., Popper H., Brcic L., „NOVEL STEREOTACTIC BODY RADIATION THERAPY (SBRT)-BASED PARTIAL TUMOR IRRADIATION TARGETING HYPOXIC SEGMENT OF BULKY TUMORS (SBRT-PATHY): IMPROVEMENT OF THE RADIOTHERAPY OUTCOME BY EXPLOITING THE BYSTANDER AND ABSCOPAL EFFECTS. Radiat Oncol. 2019
Tubin S., Khan M.M., Salerno G., Mourad F.W., Yan W., Jeremic B. “Mono-institutional Phase 2 Study of Innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) Clonogenic Cells in Unresectable Bulky Non-Small Cell Lung Cancer: Profound Non-Targeted Effects by Sparing Peri-Tumoral Immune Microenvironment.” Radiat Oncol. 2019
Tubin S, Ashdown M, Jeremic B. “Time-synchronized immune-guided SBRT partial bulky tumor irradiation targeting hypoxic segment while sparing the peritumoral immune microenvironment.” Radiat Oncol. 2019
Tubin S, Yan W, Mourad WF, Fossati P, Khan MK. “The future of radiation-induced abscopal response: beyond conventional radiotherapy approaches.” Future Oncol. 2020
Tubin S, Gupta S, Grusch M, Popper HH, Brcic L, Ashdown ML, Khleif SN, Peter-Vörösmarty B, Hyden M, Negrini S, Fossati P, Hug E. Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY). Cancers. 2021
Tubin S, Khan MK, Gupta S, Jeremic B. Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment. Cancers. 2021
Mazzola R, Cuccia F, Bertani A, Tubin S, Conaldi PG, Corradini S, Tolia M, Guba M, Alongi F. The role of radiotherapy in patients with solid tumours after solid organ transplantation: a systematic review. Lancet Oncol. 2021
Tubin S, Fossati P, Carlino A, Martino G, Gora J, Stock M, Hug E. Novel Carbon Ion and Proton Partial Irradiation of Recurrent Unresectable Bulky Tumors (Particle-PATHY): Early Indication of Effectiveness and Safety. Cancers (Basel). 2022
Tubin S, Vozenin M.C. Prezado Y, Durante M, Prise K, Lara PC, Greco C, Massaccesi M, Guha C, Wu X, Mohiuddin M.M, Vestergaard A, Bassler N, Gupta S, Stock M. Timmerman R. Novel Unconventional Radiotherapy Techniques: Current Status and Future Perspectives – report from the 2nd International Radiation Oncology Online Seminar; ctro 2023
Tubin S, Fossati P, Mock U, Luetgendorf-Caucig C,…et al…Hug E. Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-institutional Experience. Cancers 2023